Cargando…

Responsiveness and minimal clinically important difference of EQ-5D-5L in patients with coronary heart disease after percutaneous coronary intervention: A longitudinal study

BACKGROUND: Although the five-level version of the EuroQol five-dimensional questionnaire (EQ-5D-5L) has been validated in various diseases, no empirical study has evaluated the responsiveness and minimal clinically important difference (MCID) of the instrument in patients with coronary heart diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Yu, Dou, Lei, Fu, Qiang, Li, Shunping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034178/ https://www.ncbi.nlm.nih.gov/pubmed/36970361 http://dx.doi.org/10.3389/fcvm.2023.1074969

Ejemplares similares

Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease
por: Li, Chaofan, et al.
Publicado: (2023)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

Editorial: Advances in Percutaneous Coronary Intervention
por: Silverio, Angelo, et al.
Publicado: (2022)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Correlation Between Smoking Paradox and Heart Rhythm Outcomes in Patients With Coronary Artery Disease Receiving Percutaneous Coronary Intervention
por: Wu, Han-Ping, et al.
Publicado: (2022)

Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
por: Ungar, Leo, et al.
Publicado: (2018)

Temporal Trends in Complex Percutaneous Coronary Interventions
por: Kheifets, Mark, et al.
Publicado: (2022)

Editorial: Intracoronary Imaging Guidance for Percutaneous Coronary Interventions
por: Caiazzo, Gianluca, et al.
Publicado: (2022)

Development and Validation of a Prediction Model for Cardiovascular Events in Exercise Assessment of Coronary Heart Disease Patients After Percutaneous Coronary Intervention
por: Shen, Tao, et al.
Publicado: (2022)

Prognostic value of quantitative flow ratio in patients with coronary heart disease after percutaneous coronary intervention therapy: a meta-analysis
por: Chen, Huaigang, et al.
Publicado: (2023)

Case report: Constrictive pericarditis after coronary artery perforation during percutaneous coronary intervention
por: Kim, Kyung An, et al.
Publicado: (2023)

Impact of coronary collaterals on in-hospital and 5-year mortality after ST-elevation myocardial infarction in the contemporary percutaneous coronary intervention era: a prospective observational study
por: Hara, Masahiko, et al.
Publicado: (2016)

APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: the APACHE pilot study
por: Leonardi, Sergio, et al.
Publicado: (2017)

Temporal trends in relative survival following percutaneous coronary intervention
por: Hulme, William J, et al.
Publicado: (2019)

Effect of Asymptomatic Hyperuricemia on Mortality of Elderly Patients After Elective Percutaneous Coronary Intervention
por: Chen, Chen, et al.
Publicado: (2022)

Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention
por: Pinxterhuis, Tineke H., et al.
Publicado: (2023)

Quality of life measured by EQ-5D at different treatment time points for coronary artery disease: protocol for a systematic review and meta-analysis
por: Lum, Elaine, et al.
Publicado: (2020)

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease: A One-Stage Meta-Analysis
por: Chew, Nicholas W. S., et al.
Publicado: (2022)

Ten-year trends of clinical outcomes after percutaneous coronary intervention: a Korean nationwide longitudinal cohort study
por: Choi, Jung Min, et al.
Publicado: (2022)

ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention
por: Xiu, Wen-Juan, et al.
Publicado: (2022)

Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention
por: Lee, Seung-Jun, et al.
Publicado: (2022)

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
por: Tscharre, Maximilian, et al.
Publicado: (2022)

The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention
por: Chiang, Cheng-Hung, et al.
Publicado: (2022)

Hypothyroidism predicts worsened prognosis in patients undergoing percutaneous coronary intervention
por: Cohen, Ben, et al.
Publicado: (2022)

The role of intravascular imaging in chronic total occlusion percutaneous coronary intervention
por: Xenogiannis, Iosif, et al.
Publicado: (2023)

Nutritional Risk Index Improves the GRACE Score Prediction of Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Ma, Xiao-Teng, et al.
Publicado: (2021)

Sleep behaviour and cardiorespiratory fitness in patients after percutaneous coronary intervention during cardiac rehabilitation: protocol for a longitudinal study
por: Huang, Lan, et al.
Publicado: (2022)

Prognostic impact of physical activity patterns after percutaneous coronary intervention. Protocol for a prospective longitudinal cohort. The PIPAP study
por: Gonzalez-Jaramillo, Nathalia, et al.
Publicado: (2022)

Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
por: Zhao, Shujuan, et al.
Publicado: (2021)

Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention
por: Lu, Wenbin, et al.
Publicado: (2021)

A Novel Classification for Predicting Chronic Total Occlusion Percutaneous Coronary Intervention
por: Zhang, Dongfeng, et al.
Publicado: (2022)

The Role of Multimodality Imaging for Percutaneous Coronary Intervention in Patients With Chronic Total Occlusions
por: Melotti, Eleonora, et al.
Publicado: (2022)

Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions
por: Galli, Mattia, et al.
Publicado: (2023)

Primary percutaneous coronary intervention for cardio-cerebral infarction: a case report
por: Watanabe, Tomomi, et al.
Publicado: (2023)

Chronic Kidney Disease Increases Risk of Incident HFrEF Following Percutaneous Coronary Intervention
por: Lai, Wenguang, et al.
Publicado: (2022)

Erratum: Prognostic impact of physical activity patterns after percutaneous coronary intervention. Protocol for a prospective longitudinal cohort. The PIPAP study
Publicado: (2023)

Visceral Adiposity Index Plays an Important Role in Prognostic Prediction in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome and Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention
por: Zhao, Qi, et al.
Publicado: (2021)

Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) retrospective study of coronary catheterisation and percutaneous coronary intervention
por: Li, Jing, et al.
Publicado: (2014)

Retrospective cohort analysis of Spanish national trends of coronary artery bypass grafting and percutaneous coronary intervention from 1998 to 2017
por: Carnero Alcazar, Manuel, et al.
Publicado: (2021)

Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Prior Coronary Artery Bypass Graft: Current Evidence and Future Perspectives
por: Guo, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_120rlhp9tkg4qedooqenit10f4